Loading...
NPI 1043256886 · Las Vegas, NV · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Quest Diagnostics Incorporated is a clinical medical laboratory provider located in Las Vegas, Nevada. This profile covers 498 Medicare and 544 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Quest Diagnostics Incorporated |
| Address | 4230 South Burnham Ave |
| City | Las Vegas |
| State | NV |
| ZIP | 89119 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | June 21, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $59.3M |
| Medicare | $18.2M |
QUEST DIAGNOSTICS INCORPORATED presents as a high-volume clinical medical laboratory based on its code mix and revenue profile; Medicare line items such as 80053 ($1.3M), 80061 ($1.2M), 84443 ($1.2M) and 85025 ($838.7K) reflect routine chemistry, lipid, thyroid and CBC testing, while Medicaid lines led by U0003 ($9M) and large volumes of panel codes indicate substantial molecular and screening throughput. The combination of routine chemistry, immunoassays, molecular PCR, toxicology and pathology codes shows an operator running both high-throughput automated chemistry and specialized molecular/toxicology services.
Revenue concentration on Medicare is meaningfully concentrated: the precomputed top three Medicare codes (36415, 80053, 84443) account for 31.7% of the provider's total Medicare revenue. Those three codes individually contribute material revenue on Medicare — 36415 $1.3M (11.0%), 80053 $1.3M (10.7%), and 84443 $1.2M (10.0%) — identifying specimen collection and core lab panels as primary revenue drivers.
On Medicaid the top three codes are even more concentrated around molecular and panel testing: U0003, 80050 and 80061 together make up 35.2% of Medicaid revenue. Notably U0003 alone accounts for $9M or 22.4% of Medicaid revenue, with 80050 at $2.8M (6.9%) and 80061 at $2.4M (5.9%), signaling that SARS‑CoV‑2 PCR and broad screening panels are central to the provider’s Medicaid earnings.
The provider’s payer mix is heavily Medicaid‑weighted: lifetime Medicaid revenue is $59.3M versus Medicare revenue of $18.2M, indicating Medicaid is the dominant source of billed revenue in this dataset. This scale difference implies operational emphasis on Medicaid volume and state-level contracts or networks.
Competitively, this entity is a major national-volume participant on many Medicare codes: several high‑revenue Medicare codes are in the extreme outlier category and 100th percentile (for example, 36415 ranks #29 of 86467 providers nationally and is labeled an extreme outlier, and 80053 ranks #36 of 26416, also 100th percentile extreme outlier). Those national rankings indicate throughput far above typical peers for core collection and chemistry services.
Within Nevada Medicaid the provider appears dominant for many tested services: numerous top Medicaid codes rank #1 in-state at the 100th percentile (for example U0003, 80050, 80061, 80053, 82306 and others all rank #1 of their in-state provider sets). That pattern is consistent with a statewide market-leading lab footprint for molecular, panel and common diagnostic testing.
Operationally, specimen collection and phlebotomy are a clear service-line strength: Medicare shows 36415 with 164.4K claims and $1.3M revenue (11.0% of Medicare revenue), and companion high‑volume tests such as 85025 (104.8K claims, $838.7K) and 83036 (67.6K claims, $676.1K) suggest broad outpatient collection and processing capacity. High claim counts alongside substantial revenue for collection and routine tests imply a large collection network or extensive draw service relationships with ambulatory providers.
The provider’s portfolio also includes specialized molecular, toxicology and immunology testing beyond routine chemistry: Medicaid shows U0003 at $9M and 87636 at $932.4K for multiplex respiratory molecular testing, while toxicology/definitive testing appears in both payers (G0480 $408.1K Medicare and $1.3M Medicaid) and presumptive drug screens (80307). Additional entries like 88305 (surgical pathology) and 88175 (cytology) demonstrate capacity across pathology and cytology services, indicating a diversified diagnostic offering rather than a narrow test mix.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
498 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 164,370 | $10 | $1.3M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 127,310 | $10 | $1.3M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 74,920 | $20 | $1.2M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 91,020 | $10 | $1.2M |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 33,030 | $30 | $957.9K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 104,840 | $10 | $838.7K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 17,110 | $40 | $684.5K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 67,610 | $10 | $676.1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3,640 | $110 | $408.1K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 22,020 | $20 | $330.2K |
Showing 1–10 of 498
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 498 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
498 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| G0480 | 2 | 10 | 230 | $110 | $118.9K |
| 83970 | 1 | 10 | 220 | $40 | $107.6K |
| 88185 | 1 | 10 | 5,240 | $20 | $97.7K |
| 86003 | 1 | 10 | 18,810 | $10 | $96K |
| 86235 | 1 | 10 | 5,400 | $20 | $94.3K |
| G0483 | 10 | 30 | 70 | $240 | $74.8K |
| G0481 | 16 | 20 | 130 | $150 | $74.5K |
| 81479 | 1 | 10 | 180 | $410 | $73K |
| 82024 | 1 | 10 | 1,790 | $40 | $67.8K |
| 83520 | 1 | 10 | 3,820 | $20 | $64.6K |
Showing 1–10 of 498
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
544 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 134,410 | $70 | $9M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 345,940 | $10 | $2.8M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 792,600 | $1 | $2.4M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 778,230 | $1 | $2.3M |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 328,840 | $10 | $2.3M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 279,690 | $10 | $2.2M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 279,200 | $10 | $2.2M |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 54,910 | $30 | $1.7M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 418,190 | $1 | $1.7M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 110,310 | $10 | $1.4M |
Showing 1–10 of 544
How this provider's Medicaid billing volume and revenue compare to other Nevada providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Nevada median
544 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 1 | 10 | 27,660 | $30 | $868.8K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 11 | 40 | 530 | $70 | $561K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 1 | 60 | 680 | $60 | $364.3K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 8 | 30 | 290 | $60 | $260.3K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 7 | 30 | 750 | $90 | $252.3K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 1 | 10 | 14,050 | $10 | $207.1K |
| 87902 | The lab analyst performs the technical lab test to analyze the specific genotype by nucleic acid of a specimen containing hepatitis C virus. | 1 | 10 | 3,130 | $60 | $199.5K |
| 80081 | The lab analyst performs an obstetric panel; this panel must include tests for a complete blood count with differential, a hepatitis B surface antigen test, a single–result test for HIV–1 antigens… | 1 | 10 | 160 | $20 | $195.5K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 2 | 150 | 1,440 | $20 | $193.7K |
| 87536 | A lab tests a patient’s specimen to measure the amount of HIV–1 present. This may be referred to as viral load. | 1 | 10 | 9,790 | $20 | $189K |
Showing 1–10 of 544
Other providers in the same ZIP code as Quest Diagnostics Incorporated, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.